National survey of hemapheresis practice in Hungary 2001-2004

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 1, 2007, Pages 22-29

  Belák, Mihály ^a,b   Jákó, János ^a  

^a NATIONAL MEDICAL CENTER   (Hungary)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Hemapheresis; National survey; Plasma exchange

Indexed keywords

APHERESIS; ARTICLE; CLINICAL PRACTICE; EVIDENCE BASED PRACTICE; FINANCIAL MANAGEMENT; HEALTH SURVEY; HUNGARY; MEDICAL EXPERT; MEDICAL LITERATURE; NATIONAL HEALTH INSURANCE; PLASMAPHERESIS; PRIORITY JOURNAL; REGISTER; REIMBURSEMENT;

ARTHRITIS, RHEUMATOID; BLOOD COMPONENT REMOVAL; CANADA; GUILLAIN-BARRE SYNDROME; HEALTH SURVEYS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HUNGARY; MYASTHENIA GRAVIS; NATIONAL HEALTH PROGRAMS; PHYSICIAN'S PRACTICE PATTERNS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 33846996339     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00414.x     Document Type: Article

References (38)

1. European Society for Haemapheresis and Haemotherapy. Löliger H, Mansouri Taleghani U, Ullrich G, Wiesneth T, Borberg H. Recommendations for the application of haemapheresis in medicine. [Cited 4 May 2005.] Available at: http://www.esfh.org/Recommendations.htm
2. Andrzejewski C, Coleman M, Jost Golden P, Zielinski I, Weinstein R. The American Society for Apheresis Therapeutic Apheresis. A Guide to Billing and Securing Appropriate Reimbursement, 2005 Edition. [Cited 4 May 2005.] Available at: http://www.apheresis.org/~documents/ASFA_Reimbursement_Guide_-_Final.pdf (see appendix 2).
3. Leitman SF et al. Guidelines for Therapeutic Hemapheresis. Bethesda, MD: American Association of Blood Banks, 1994.
4. Aetna American Insurance Company. Policy Bulletins, number 0285, Subject: Plasmapheresis/Plasma Exchange/Therapeutic Apheresis, 2004. [Cited 4 May 2005.] Available at: http://www.aetna.com/cpb/data/CPBA0285.html
5. Center for MediCare and MedicAid Services. Paper-based manuals. Coverage issues - Medical Procedures, part 35-60. [Cited 22 Jan 2007.] Available at: http://www.cms.hhs.gov/Manuals/PBM/itemdetail.asp?filterType= none&filterByDID=99&sortByDID=1&sortOrder=ascending&itemID= CMS021321&intNumPerPage=10
6. McLeod BC. Introduction to the third special issue: clinical applications of therapeutic apheresis. J Clin Apher 2000;15:1-5.
7. Smith JW, Weinstein R, Hillyer KL for the AABB Hemapheresis Committee. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003;43:821-2.
8. Clark WF et al. Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med 1999;131:453-62.
9. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clin Study Group. Ann Neurol 1997;41:789-96.
10. Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. - Evidence based medicine reviews. Cochrane Database Syst Rev 2002;4:CD002275.
11. NIH Consensus Conference. The utility of therapeutic plasmapheresis for neurological disorders. JAMA 1986;256:1333-7.
12. Assessment Subcommittee of the American Academy of Neurology. Assessment of plasmapheresis. Report of the Therapeutics and Technology Neurology 1996;47:840-3.
13. Kaplan AA. A Practical Guide to Therapeutic Plasma Exchange. Malden, MA: Blackwell Publishing, 1999.
14. Osterman PO et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984;2:1296-9.
15. The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.
16. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol 1987;22:753-61.
17. van der Meché FG, Schmitz PI. A randomised trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med 1992;326:1123-9.
18. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-30.
19. Raphael JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. - Evidence Based Medicine Reviews. Cochrane Database Syst Rev 2002;2:CD001798. Review.
20. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-9.
21. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-5.
22. Barth WF, Wochner D, Waldmann TA, Fahey JL. Metabolism of human gamma macroglobulins. J Clin Invest 1964;43:1036-48.
23. Isbister JP, Biggs JC, Penny R. Experience with large Volume plasmapheresis in malignant paraproteinemia and immune disorders. Aust N Z J Med 1978;8:154-64.
24. Cohen S, Freeman T. Metabolic heterogeneity of human gamma globulin. Biochem J 1960;76:475-87.
25. Kaplan AA. Towards a rational prescription of plasma exchange: the kinetics of immunoglobulin removal. Semin Dial 1992;5:227-9.
26. Amorsi EL, Ultman JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 1966;45:139-59.
27. Lawrence MT, McPhee SJ, Papadakis MA. Korszerû orvosi diagnosztika és terápia [Current Medical Diagnosis and Treatment]. Maidenhead: Appleton & Lange, 2003.
28. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Eng J Med 1998;339:1585-94.
29. Lammle B, Kremer Hovinga JA, Alberio L. Thrombotic thrombocytopenic purpura. J Thromb Haemost 2005;3:1663-75.
30. Bohm M et al. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine. Br J Haematol 2005;129:644-52.
31. Rock GA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Can Apheresis Study Group. N Engl J Med 1991;325:393-7.
32. American College of Physicians (ACP) Journal Club. Plasma exchange was more effective than plasma infusion for thrombotic thrombocythopenic purpura. ACP Journal Club. Evid Based Med Rev 1991;115:81.
33. Goldman JA, Casey HL, McIlwain H, Kirby J, Wilson CH Jr, Miller SB. Limited plasmapheresis in rheumatoid arthritis with vasculitis. Arthritis Rheum 1979;22:1146-50.
34. Scott DGI et al. Plasma exchange in rheumatoid vasculitis. J Rheumatol 1981;8:433-9.
35. Kosaka M, Solomon A. Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor. Am J Med 1980;69:145-54.
36. Dwosh IL, Giles AR, Ford PM, Pater JL, Anastassiades TP. Plasmapheresis therapy in rheumatoid arthritis (A controlled, double-blind, crossover trial) N Engl J Med 1983;306:1124-9.
37. Braun-Moscovici Y, Furst DE. Plasmapheresis for rheuamatic disease in the twenty-first century: take it or leave it? Curr Opin Rheumatol 2003;15:197-204.
38. Wallace D et al. A Double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. N Engl J Med 1982;306:1406-10.